238 related articles for article (PubMed ID: 35413115)
21. Elevated CLOCK and BMAL1 Contribute to the Impairment of Aerobic Glycolysis from Astrocytes in Alzheimer's Disease.
Yoo ID; Park MW; Cha HW; Yoon S; Boonpraman N; Yi SS; Moon JS
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114015
[TBL] [Abstract][Full Text] [Related]
22. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract][Full Text] [Related]
23. Circadian Clock in a Mouse Colon Tumor Regulates Intracellular Iron Levels to Promote Tumor Progression.
Okazaki F; Matsunaga N; Okazaki H; Azuma H; Hamamura K; Tsuruta A; Tsurudome Y; Ogino T; Hara Y; Suzuki T; Hyodo K; Ishihara H; Kikuchi H; To H; Aramaki H; Koyanagi S; Ohdo S
J Biol Chem; 2016 Mar; 291(13):7017-28. PubMed ID: 26797126
[TBL] [Abstract][Full Text] [Related]
24. Intermolecular recognition revealed by the complex structure of human CLOCK-BMAL1 basic helix-loop-helix domains with E-box DNA.
Wang Z; Wu Y; Li L; Su XD
Cell Res; 2013 Feb; 23(2):213-24. PubMed ID: 23229515
[TBL] [Abstract][Full Text] [Related]
25. CLOCK and BMAL1 regulate MyoD and are necessary for maintenance of skeletal muscle phenotype and function.
Andrews JL; Zhang X; McCarthy JJ; McDearmon EL; Hornberger TA; Russell B; Campbell KS; Arbogast S; Reid MB; Walker JR; Hogenesch JB; Takahashi JS; Esser KA
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19090-5. PubMed ID: 20956306
[TBL] [Abstract][Full Text] [Related]
26. Mammalian Period represses and de-represses transcription by displacing CLOCK-BMAL1 from promoters in a Cryptochrome-dependent manner.
Chiou YY; Yang Y; Rashid N; Ye R; Selby CP; Sancar A
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6072-E6079. PubMed ID: 27688755
[TBL] [Abstract][Full Text] [Related]
27. Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock.
Lee Y; Lee J; Kwon I; Nakajima Y; Ohmiya Y; Son GH; Lee KH; Kim K
J Cell Sci; 2010 Oct; 123(Pt 20):3547-57. PubMed ID: 20930143
[TBL] [Abstract][Full Text] [Related]
28. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma.
Pang L; Dunterman M; Guo S; Khan F; Liu Y; Taefi E; Bahrami A; Geula C; Hsu WH; Horbinski C; James CD; Chen P
Nat Immunol; 2023 Oct; 24(10):1654-1670. PubMed ID: 37667051
[TBL] [Abstract][Full Text] [Related]
29. Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
Dumas AA; Pomella N; Rosser G; Guglielmi L; Vinel C; Millner TO; Rees J; Aley N; Sheer D; Wei J; Marisetty A; Heimberger AB; Bowman RL; Brandner S; Joyce JA; Marino S
EMBO J; 2020 Aug; 39(15):e103790. PubMed ID: 32567735
[TBL] [Abstract][Full Text] [Related]
30. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
31. Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma.
Slat EA; Sponagel J; Marpegan L; Simon T; Kfoury N; Kim A; Binz A; Herzog ED; Rubin JB
J Biol Rhythms; 2017 Apr; 32(2):121-129. PubMed ID: 28470120
[TBL] [Abstract][Full Text] [Related]
32. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
[TBL] [Abstract][Full Text] [Related]
34. Silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis to promote GBM sensitivity to bevacizumab.
Wang F; Liao W; Li C; Zhu L
Int Immunopharmacol; 2024 Jun; 134():112187. PubMed ID: 38733825
[TBL] [Abstract][Full Text] [Related]
35. Disrupted-in-schizophrenia 1 enhances the quality of circadian rhythm by stabilizing BMAL1.
Lee SB; Park J; Kwak Y; Park YU; Nhung TTM; Suh BK; Woo Y; Suh Y; Cho E; Cho S; Park SK
Transl Psychiatry; 2021 Feb; 11(1):110. PubMed ID: 33542182
[TBL] [Abstract][Full Text] [Related]
36. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
38. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
[TBL] [Abstract][Full Text] [Related]
39. Circadian oscillation of TNF-α gene expression regulated by clock gene, BMAL1 and CLOCK1, in the Japanese medaka (Oryzias latipes).
Onoue T; Nishi G; Hikima JI; Sakai M; Kono T
Int Immunopharmacol; 2019 May; 70():362-371. PubMed ID: 30852291
[TBL] [Abstract][Full Text] [Related]
40. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
